Literature DB >> 14746909

Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb.

Eija Pirinen1, Sami Heikkinen, Mari Malkki, Samir S Deeb, Juhani Jänne, Markku Laakso.   

Abstract

To locate regulatory element(s) that mediate(s) the effect of insulin on hexokinase II (HKII) gene transcription, we have generated several transgenic mouse lines harboring 97, 254, 505, 819 or 4077 bp of the proximal promoter of the human HKII gene driving the expression of a luciferase reporter gene. Luciferase activities indicate that major promoter elements responsible for the basal activity and tissue-specificity of the human HKII gene expression are located within the 505-bp segment of the promoter. To induce the promoter constructs by endogenous insulin released from the pancreatic beta-cells, transgenic mice were given repeated intraperitoneal injections of D-glucose. Significant induction of luciferase activity was not observed in any of the transgenic mouse lines even though the endogenous HKII mRNA was induced 2.7-fold upon treatment. Thus, our results suggest a lack of insulin response in the 4.0-kb region of the proximal promoter of the human HKII gene in mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14746909     DOI: 10.1016/j.bbaexp.2003.11.007

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

Review 1.  Emerging metabolic targets in the therapy of hematological malignancies.

Authors:  Zaira Leni; Geetha Parakkal; Alexandre Arcaro
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

2.  Costunolide reduces glycolysis-associated activation of hepatic stellate cells via inhibition of hexokinase-2.

Authors:  Dujing Ban; Shangbo Hua; Wen Zhang; Chao Shen; Xuehua Miao; Wensheng Liu
Journal:  Cell Mol Biol Lett       Date:  2019-08-14       Impact factor: 5.787

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.